Skip to main content
. 2021 Nov 12;49(11):03000605211055378. doi: 10.1177/03000605211055378

Figure 5.

Figure 5.

ROC curve assessment of the use of serum GP73, FibroScan value and their combination in the identification hepatic fibrosis stage F ≥ 2 in participants with non-alcoholic fatty liver disease. N = 91.

ROC, receiver operating characteristic; GP, Golgi protein.